Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1105-2021Class II

Bemer-Set/ Pro-Set for the following models: REF. 410201 (BEMER Pro-Set), REF. 420201 (B.BOX Professional)...

BEMER Int. AG / initiated 2021-01-13 / Terminated / root cause: labeling and UDI

BEMER INT. AG began a recall of Bemer-Set/ Pro-Set for the following models: REF. 410201 (BEMER Pro-Set), REF. 420201 (B.BOX Professional), REF. 420100 (B.BOX CLASSIC), REF. 410100 (BEMER... on . FDA classified it as Class II and gives the reason as "There potential that electromagnetic fields generated in the therapy system may cause technical defects in a patient using an insulin pumps or a malfunction of a pacemaker". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1105-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
BEMER Int. AG
Product
Bemer-Set/ Pro-Set for the following models: REF. 410201 (BEMER Pro-Set), REF. 420201 (B.BOX Professional), REF. 420100 (B.BOX CLASSIC), REF. 410100 (BEMER Classic-Set), REF. 420200 (B.BOX Professional), and REF. 410200 (BEMER Pro - Set)
Product code
NGX Stimulator, Muscle, Powered, For Muscle Conditioning
Reason for recall
There potential that electromagnetic fields generated in the therapy system may cause technical defects in a patient using an insulin pumps or a malfunction of a pacemaker.
Root cause tag
labeling and UDI
FDA root cause
Labeling Change Control
Action
On January 13, 2021, Bemer USA sent a "Urgent Safety Information" letter to affected consignees via E-Mail. In addition to informing consignees about the recall the firm asked consignees to take the following actions: 1. Patients who wear an active medical implant that leads to stimulation (e.g., pacemakers, defibrillators, brain stimulators, muscle stimulators) should not use the BEMER therapy system unless a specialist physician carries out a personal risk assessment and subsequently expressly tells the patient that he/she can continue the treatment. If you are an affected patient, please stop using the BEMER therapy system immediately and consult your specialist physician. The specialist physician will then decide whether or not you can continue using the BEMER therapy system. 2. In the risk assessment, your specialist physician must estimate whether or not the BEMER therapy can cause possible interference at a maximum flow density of 150 T (average flow density for total body treatment 21 T), based on the individually set threshold values of the implant and under consideration of the distance between the applicator (coil) and the pacemaker with its electrodes. If the specialist physician estimates that interference and therefore, operating safety, cannot be excluded, do not continue the BEMER therapy system treatment. 3. Patients wearing active medical implants designed to deliver medication (e.g., medication pumps) have an absolute contraindication. In other words, they may no longer use the BEMER therapy system. These contraindications must be observed by the user for future use. 4. If you have re-sold the aforementioned products in new condition to a third party, you are required to forward a copy of this notice to all your customers, including all professional users (doctors, therapists, hospitals, etc.). Alternatively, please inform the contact person listed below so we can ensure the compliance with this notice requirement. Your applicabl
Quantity in commerce
197,724 units
Distribution
US
Product codes and lots
All Lot Numbers

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1105-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1105-2021Class IITerminatedVoluntary: Firm initiated